Legislation & Regulation
John Carroll
Critics say insurers fail to make a distinction between those who commit fraud and those who simply make mistakes
Medication Management
Martin Sipkoff
Overusing erythropoiesis-stimulating agents to collect rebates can be really bad for the patient. Ripping off taxpayers and private payers is another concern.
Tomorrow's Medicine
Thomas Morrow, MD
Questions about study design and analysis prompted the agency to postpone action on Provenge, a treatment for advanced prostate cancer
Employer Update
Lola Butcher
In board rooms across the country, decisions are being made to battle, rather than run from, rising costs of care
News and Commentary
News and Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report